Head-to-head
Ivim Health vs Hims & Hers
Compared on both medications across the eight dimensions this database records. They differ on 6 of those eight. Ivim Health is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Ivim Health is $353 a month all-in for tirzepatide; Hims & Hers is $697. Over twelve months that is $4,236 against $8,364. Value Scores are 46.3 and 27.5 out of 100.
Tirzepatide
Plan pages: Ivim Health plans · Hims & Hers plans
At 10 mg/week, Ivim Health is $353 a month all-in and Hims & Hers is $697 — $344 apart, or $4,128 across a year. Over twelve months the totals are $4,236 (billed monthly) and $8,364 (billed monthly).
Ivim Health prices tirzepatide by dose: $208 per month at 2.5 mg rising to $278 at 10 mg, a difference of $70 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
Hims & Hers charges a flat $548 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | Ivim Health | Rank | Hims & Hers | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $208 | 10/31 | $548 | 30/31 | Ivim Health by $340 |
| 5 mg | — | — | — | — | neither publishes |
| 7.5 mg | — | — | — | — | neither publishes |
| 10 mg | $278 | 7/27 | $548 | 25/27 | Ivim Health by $270 |
| 12.5 mg | — | — | — | — | neither publishes |
| 15 mg | — | — | — | — | neither publishes |
Ivim Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Ivim Health sits 16 of 27 on all-in monthly cost and Hims & Hers sits 25. There are 8 other programs priced between them. The field median is $339 and the floor is $169, so both sit above the median. Ivim Health is $184 above the cheapest tirzepatide program on record. Hims & Hers is $528 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Ivim Health undercuts it by $96, Hims & Hers by $-248. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Ivim Health | Hims & Hers | Cheaper |
|---|---|---|---|
| Month to month | $278 | $548 | Ivim Health by $270 |
| Settled dose | Ivim Health | Hims & Hers | Difference |
|---|---|---|---|
| 2.5 mg | $3,396 | $8,364 | $4,968 apart |
| 10 mg | $4,236 | $8,364 | $4,128 apart |
Ivim Health publishes no rate for 3-month term, 6-month term, 12-month term; Hims & Hers publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,166 on Ivim Health and $8,364 on Hims & Hers — $4,198 apart, and a different gap from the $4,128 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Ivim Health publishes no price at 2 of the 6 doses and Hims & Hers publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 46.3 for Ivim Health and 27.5 for Hims & Hers, against a tirzepatide category floor of $169. Ivim Health leads by 18.8 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Ivim Health | 33.5 | 12.8 | 0 | 0 | 46.3 |
| Hims & Hers | 17.0 | 10.5 | 0 | 0 | 27.5 |
Semaglutide
Plan pages: Ivim Health plans · Hims & Hers plans
At 2.4 mg/week, Ivim Health is $224 a month all-in and Hims & Hers is $602 — $378 apart, or $4,536 across a year. Over twelve months the totals are $2,688 (billed monthly) and $7,224 (billed monthly).
Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Hims & Hers charges a flat $453 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Ivim Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 53.1 for Ivim Health and 25.5 for Hims & Hers, against a semaglutide category floor of $129. Ivim Health leads by 27.6 points, driven mostly by price.
Where the two programs differ
All-in monthly
Ivim Health is cheaper month to month — $353 against $697, a gap of $344 every month, or $4,128 across a year if both rates hold.
Commitment
Ivim Health asks for Month-to-month; Hims & Hers asks for Membership month-to-month ($39 first month). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. Ivim Health's figure is provider-stated and Hims & Hers's is reported. Ivim Health rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Membership fee
Ivim Health charges a membership of $75 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Shipping
Hims & Hers bills shipping separately at $5; the other includes it.
Twelve-month cost
Over twelve months the totals are $4,236 for Ivim Health and $8,364 for Hims & Hers. Ivim Health is lower by $4,128 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Cancellation terms
Both state the same cancellation terms: Cancel anytime.
Dose policy
Both price by dose, so both advertised figures understate the cost of a titration year. Compare the ladders above rather than the headline rates.
What each record says
Ivim Health Official site
Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05
Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
Hims & Hers Official site
After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
It names its compounding pharmacy — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy, recorded as Brand channel — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Membership month-to-month ($39 first month); cancellation is Cancel anytime; availability is stated as 50 states.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — Post-settlement pricing reported May–Jun 2026 (Wegovy $299 / oral $249 / Zepbound $399 + $149 membership + $5 shipping); first-party checkout capture pending
Watch: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
What neither record tells you
Ivim Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says ~50 states
Hims & Hers does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
Ask Ivim Health and Hims & Hers for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Hims & Hers carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Ivim Health Official site wins this matchup. If you want to be able to pause without still paying, hims & hers carries no membership; and if you would rather trust a better-evidenced number, ivim health's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Ivim Health's tirzepatide price is provider-stated as of 2026-08-05; Hims & Hers's is reported as of 2026-08-11.
Questions
Is Ivim Health or Hims & Hers cheaper for tirzepatide?
Ivim Health is cheaper on all-in monthly cost at 10 mg/week: $353 against $697, a difference of $344 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Ivim Health versus Hims & Hers?
Ivim Health works out to $4,236 across twelve months and Hims & Hers to $8,364, on the plan terms each publishes.
Does Ivim Health or Hims & Hers raise the price as the dose goes up?
Ivim Health: yes, it prices by dose. Hims & Hers: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Ivim Health and Hims & Hers differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Ivim Health and Hims & Hers names its pharmacy?
Hims & Hers does — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy. Ivim Health does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the Ivim Health and Hims & Hers prices?
Ivim Health's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Hims & Hers's is reported, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Ivim Health, at $224 a month all-in against $602 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Ivim Health official site · Hims & Hers official site. Compounded tirzepatide and semaglutide are not FDA-approved products.